PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2010; 5(10): 10.1371/annotation/bdcb41f2-a320-4401-a6ab-86e71738597e.
Published online 2010 October 29. doi:  10.1371/annotation/bdcb41f2-a320-4401-a6ab-86e71738597e
PMCID: PMC2976855

Correction: Extracranial Sources of S100B Do Not Affect Serum Levels

In our recent article [1], we did not declare several potential competing interests relevant to this work. We apologize for this omission and would like to disclose the following information:

Dr. Janigro has received royalty payments from Roche Diagnostics and holds a patent on S100B for its use as a serum marker for blood-brain barrier leakage.

The study was partly supported by Roche Diagnostics. The company does not currently develop any products related to the results described in the article.

Reference:

1. Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, Janigro D (2010) Extracranial sources of S100B do not affect serum levels. PLoS One 5(9): e12691. doi:10.1371/journal.pone.0012691

Footnotes

Competing Interests: No competing interests declared.


Articles from PLoS ONE are provided here courtesy of Public Library of Science